The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Paclitaxel-Global Market Insights and Sales Trends 2025
Synopsis
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
The global Paclitaxel market size is expected to reach US$ 205.5 million by 2029, growing at a CAGR of 8.2% from 2023 to 2029. The market is mainly driven by the significant applications of Paclitaxel in various end use industries. The expanding demands from the Ovarian Cancer, Cervical Cancer, Breast Cancer and Others, are propelling Paclitaxel market. Natural Paclitaxel API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Semi-synthetic Paclitaxel API segment is estimated at % CAGR for the next seven-year period.
North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Paclitaxel, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Paclitaxel market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Paclitaxel market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Paclitaxel sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Paclitaxel covered in this report include Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma and Southpharma, etc.
The global Paclitaxel market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Global Paclitaxel market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Paclitaxel market, Segment by Type:
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Global Paclitaxel market, by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Paclitaxel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Paclitaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
The global Paclitaxel market size is expected to reach US$ 205.5 million by 2029, growing at a CAGR of 8.2% from 2023 to 2029. The market is mainly driven by the significant applications of Paclitaxel in various end use industries. The expanding demands from the Ovarian Cancer, Cervical Cancer, Breast Cancer and Others, are propelling Paclitaxel market. Natural Paclitaxel API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Semi-synthetic Paclitaxel API segment is estimated at % CAGR for the next seven-year period.
North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Paclitaxel, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Paclitaxel market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Paclitaxel market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Paclitaxel sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Paclitaxel covered in this report include Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma and Southpharma, etc.
The global Paclitaxel market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Global Paclitaxel market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Paclitaxel market, Segment by Type:
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Global Paclitaxel market, by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Paclitaxel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Paclitaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Paclitaxel Market Overview
1.1 Paclitaxel Product Overview
1.2 Paclitaxel Market Segment by Type
1.2.1 Natural Paclitaxel API
1.2.2 Semi-synthetic Paclitaxel API
1.3 Global Paclitaxel Market Size by Type
1.3.1 Global Paclitaxel Market Size Overview by Type (2018-2029)
1.3.2 Global Paclitaxel Historic Market Size Review by Type (2018-2023)
1.3.3 Global Paclitaxel Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Paclitaxel Sales Breakdown by Type (2018-2023)
1.4.2 Europe Paclitaxel Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Paclitaxel Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Paclitaxel Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Paclitaxel Sales Breakdown by Type (2018-2023)
2 Global Paclitaxel Market Competition by Company
2.1 Global Top Players by Paclitaxel Sales (2018-2023)
2.2 Global Top Players by Paclitaxel Revenue (2018-2023)
2.3 Global Top Players by Paclitaxel Price (2018-2023)
2.4 Global Top Manufacturers Paclitaxel Manufacturing Base Distribution, Sales Area, Product Type
2.5 Paclitaxel Market Competitive Situation and Trends
2.5.1 Paclitaxel Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Paclitaxel Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Paclitaxel as of 2022)
2.7 Date of Key Manufacturers Enter into Paclitaxel Market
2.8 Key Manufacturers Paclitaxel Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Paclitaxel Status and Outlook by Region
3.1 Global Paclitaxel Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Paclitaxel Historic Market Size by Region
3.2.1 Global Paclitaxel Sales in Volume by Region (2018-2023)
3.2.2 Global Paclitaxel Sales in Value by Region (2018-2023)
3.2.3 Global Paclitaxel Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Paclitaxel Forecasted Market Size by Region
3.3.1 Global Paclitaxel Sales in Volume by Region (2024-2029)
3.3.2 Global Paclitaxel Sales in Value by Region (2024-2029)
3.3.3 Global Paclitaxel Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Paclitaxel by Application
4.1 Paclitaxel Market Segment by Application
4.1.1 Ovarian Cancer
4.1.2 Cervical Cancer
4.1.3 Breast Cancer
4.1.4 Others
4.2 Global Paclitaxel Market Size by Application
4.2.1 Global Paclitaxel Market Size Overview by Application (2018-2029)
4.2.2 Global Paclitaxel Historic Market Size Review by Application (2018-2023)
4.2.3 Global Paclitaxel Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Paclitaxel Sales Breakdown by Application (2018-2023)
4.3.2 Europe Paclitaxel Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Paclitaxel Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Paclitaxel Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Paclitaxel Sales Breakdown by Application (2018-2023)
5 North America Paclitaxel by Country
5.1 North America Paclitaxel Historic Market Size by Country
5.1.1 North America Paclitaxel Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Paclitaxel Sales in Volume by Country (2018-2023)
5.1.3 North America Paclitaxel Sales in Value by Country (2018-2023)
5.2 North America Paclitaxel Forecasted Market Size by Country
5.2.1 North America Paclitaxel Sales in Volume by Country (2024-2029)
5.2.2 North America Paclitaxel Sales in Value by Country (2024-2029)
6 Europe Paclitaxel by Country
6.1 Europe Paclitaxel Historic Market Size by Country
6.1.1 Europe Paclitaxel Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Paclitaxel Sales in Volume by Country (2018-2023)
6.1.3 Europe Paclitaxel Sales in Value by Country (2018-2023)
6.2 Europe Paclitaxel Forecasted Market Size by Country
6.2.1 Europe Paclitaxel Sales in Volume by Country (2024-2029)
6.2.2 Europe Paclitaxel Sales in Value by Country (2024-2029)
7 Asia-Pacific Paclitaxel by Region
7.1 Asia-Pacific Paclitaxel Historic Market Size by Region
7.1.1 Asia-Pacific Paclitaxel Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Paclitaxel Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Paclitaxel Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Paclitaxel Forecasted Market Size by Region
7.2.1 Asia-Pacific Paclitaxel Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Paclitaxel Sales in Value by Region (2024-2029)
8 Latin America Paclitaxel by Country
8.1 Latin America Paclitaxel Historic Market Size by Country
8.1.1 Latin America Paclitaxel Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Paclitaxel Sales in Volume by Country (2018-2023)
8.1.3 Latin America Paclitaxel Sales in Value by Country (2018-2023)
8.2 Latin America Paclitaxel Forecasted Market Size by Country
8.2.1 Latin America Paclitaxel Sales in Volume by Country (2024-2029)
8.2.2 Latin America Paclitaxel Sales in Value by Country (2024-2029)
9 Middle East and Africa Paclitaxel by Country
9.1 Middle East and Africa Paclitaxel Historic Market Size by Country
9.1.1 Middle East and Africa Paclitaxel Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Paclitaxel Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Paclitaxel Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Paclitaxel Forecasted Market Size by Country
9.2.1 Middle East and Africa Paclitaxel Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Paclitaxel Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Phyton
10.1.1 Phyton Company Information
10.1.2 Phyton Introduction and Business Overview
10.1.3 Phyton Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Phyton Paclitaxel Products Offered
10.1.5 Phyton Recent Development
10.2 ScinoPharm
10.2.1 ScinoPharm Company Information
10.2.2 ScinoPharm Introduction and Business Overview
10.2.3 ScinoPharm Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
10.2.4 ScinoPharm Paclitaxel Products Offered
10.2.5 ScinoPharm Recent Development
10.3 Novasep
10.3.1 Novasep Company Information
10.3.2 Novasep Introduction and Business Overview
10.3.3 Novasep Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novasep Paclitaxel Products Offered
10.3.5 Novasep Recent Development
10.4 Samyang
10.4.1 Samyang Company Information
10.4.2 Samyang Introduction and Business Overview
10.4.3 Samyang Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Samyang Paclitaxel Products Offered
10.4.5 Samyang Recent Development
10.5 Polymed
10.5.1 Polymed Company Information
10.5.2 Polymed Introduction and Business Overview
10.5.3 Polymed Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Polymed Paclitaxel Products Offered
10.5.5 Polymed Recent Development
10.6 TAPI (Teva)
10.6.1 TAPI (Teva) Company Information
10.6.2 TAPI (Teva) Introduction and Business Overview
10.6.3 TAPI (Teva) Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
10.6.4 TAPI (Teva) Paclitaxel Products Offered
10.6.5 TAPI (Teva) Recent Development
10.7 Fresenius-kabi
10.7.1 Fresenius-kabi Company Information
10.7.2 Fresenius-kabi Introduction and Business Overview
10.7.3 Fresenius-kabi Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Fresenius-kabi Paclitaxel Products Offered
10.7.5 Fresenius-kabi Recent Development
10.8 Huiang biopharma
10.8.1 Huiang biopharma Company Information
10.8.2 Huiang biopharma Introduction and Business Overview
10.8.3 Huiang biopharma Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Huiang biopharma Paclitaxel Products Offered
10.8.5 Huiang biopharma Recent Development
10.9 Southpharma
10.9.1 Southpharma Company Information
10.9.2 Southpharma Introduction and Business Overview
10.9.3 Southpharma Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Southpharma Paclitaxel Products Offered
10.9.5 Southpharma Recent Development
10.10 Yunnan Hande
10.10.1 Yunnan Hande Company Information
10.10.2 Yunnan Hande Introduction and Business Overview
10.10.3 Yunnan Hande Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Yunnan Hande Paclitaxel Products Offered
10.10.5 Yunnan Hande Recent Development
10.11 Hainan Yew Pharm
10.11.1 Hainan Yew Pharm Company Information
10.11.2 Hainan Yew Pharm Introduction and Business Overview
10.11.3 Hainan Yew Pharm Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hainan Yew Pharm Paclitaxel Products Offered
10.11.5 Hainan Yew Pharm Recent Development
10.12 Jiangsu Yew Biotechnology
10.12.1 Jiangsu Yew Biotechnology Company Information
10.12.2 Jiangsu Yew Biotechnology Introduction and Business Overview
10.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Jiangsu Yew Biotechnology Paclitaxel Products Offered
10.12.5 Jiangsu Yew Biotechnology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Paclitaxel Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Paclitaxel Industrial Chain Analysis
11.4 Paclitaxel Market Dynamics
11.4.1 Paclitaxel Industry Trends
11.4.2 Paclitaxel Market Drivers
11.4.3 Paclitaxel Market Challenges
11.4.4 Paclitaxel Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Paclitaxel Distributors
12.3 Paclitaxel Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
